Fabricated interview about NYC mayoral candidate Mamdani sparks scrutiny of candidates and media reporting in final days of race.
Earnings reports show mixed performances for Lynas Rare Earths, NOV Inc., Clean Harbors, and Labcorp Holdings, with challenges, adjustments, and cautious outlooks amid market volatility.
Novartis to acquire Avidity Biosciences for $12 billion, bolstering its neuroscience pipeline with late-stage programs.
Fabricated interview about NYC mayoral candidate Mamdani sparks scrutiny of candidates and media reporting in final days of race.
Earnings reports show mixed performances for Lynas Rare Earths, NOV Inc., Clean Harbors, and Labcorp Holdings, with challenges, adjustments, and cautious outlooks amid market volatility.
Novartis to acquire Avidity Biosciences for $12 billion, bolstering its neuroscience pipeline with late-stage programs.